Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 16;94(15):e00831-20.
doi: 10.1128/JVI.00831-20. Print 2020 Jul 16.

Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts

Affiliations

Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts

Xiaofeng Zhai et al. J Virol. .

Abstract

The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in a pandemic. Here, we used X-ray structures of human ACE2 bound to the receptor-binding domain (RBD) of the spike protein (S) from SARS-CoV-2 to predict its binding to ACE2 proteins from different animals, including pets, farm animals, and putative intermediate hosts of SARS-CoV-2. Comparing the interaction sites of ACE2 proteins known to serve or not serve as receptors allows the definition of residues important for binding. From the 20 amino acids in ACE2 that contact S, up to 7 can be replaced and ACE2 can still function as the SARS-CoV-2 receptor. These variable amino acids are clustered at certain positions, mostly at the periphery of the binding site, while changes of the invariable residues prevent S binding or infection of the respective animal. Some ACE2 proteins even tolerate the loss or acquisition of N-glycosylation sites located near the S interface. Of note, pigs and dogs, which are not infected or are not effectively infected and have only a few changes in the binding site, exhibit relatively low levels of ACE2 in the respiratory tract. Comparison of the RBD of S of SARS-CoV-2 with that from bat coronavirus strain RaTG13 (Bat-CoV-RaTG13) and pangolin coronavirus (Pangolin-CoV) strain hCoV-19/pangolin/Guangdong/1/2019 revealed that the latter contains only one substitution, whereas Bat-CoV-RaTG13 exhibits five. However, ACE2 of pangolin exhibits seven changes relative to human ACE2, and a similar number of substitutions is present in ACE2 of bats, raccoon dogs, and civets, suggesting that SARS-CoV-2 may not be especially adapted to ACE2 of any of its putative intermediate hosts. These analyses provide new insight into the receptor usage and animal source/origin of SARS-CoV-2.IMPORTANCE SARS-CoV-2 is threatening people worldwide, and there are no drugs or vaccines available to mitigate its spread. The origin of the virus is still unclear, and whether pets and livestock can be infected and transmit SARS-CoV-2 are important and unknown scientific questions. Effective binding to the host receptor ACE2 is the first prerequisite for infection of cells and determines the host range. Our analysis provides a framework for the prediction of potential hosts of SARS-CoV-2. We found that ACE2 from species known to support SARS-CoV-2 infection tolerate many amino acid changes, indicating that the species barrier might be low. Exceptions are dogs and especially pigs, which revealed relatively low ACE2 expression levels in the respiratory tract. Monitoring of animals is necessary to prevent the generation of a new coronavirus reservoir. Finally, our analysis also showed that SARS-CoV-2 may not be specifically adapted to any of its putative intermediate hosts.

Keywords: SARS-CoV-2; angiotensin-converting enzyme 2; livestock; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Figures

FIG 1
FIG 1
(A) Interaction surface of SARS-CoV-2 S (green) and human ACE2 (blue). Amino acids involved in contact are shown in magenta for S or as orange (amino acids forming hydrogen bonds) and cyan (hydrophobic interaction) sticks for ACE2. D30 forms a salt bridge with K417 in S of SARS-CoV-2. The figure was created with PyMol from PDB file 6MOJ. (B) Interaction surface between SARS-CoV S (green) and human ACE2 (blue). Amino acids making contact are shown in magenta (S) or orange (ACE2) sticks. The three amino acids in ACE2 that are not involved in binding of S from SARS-CoV-2 are shown as cyan sticks. The side chain of D30 that forms a salt bridge with S of SARS-CoV-2 is pointing away from the interacting surface. Inset, detail of the interaction between R426 that forms a salt bridge with E329 and a hydrogen bond with Q325. The figure was created with PyMol from PDB file 2AJF.
FIG 2
FIG 2
(A) Amino acid changes of human ACE2 and pig ACE2. Amino acid changes in ACE2 from pigs in comparison with human ACE2 are highlighted in red. N90 is not an interaction site, but the change N90T destroys the N-glycosylation site present in human ACE2. (B) Amino acid changes in human ACE2 and civet ACE2. Amino acid changes in ACE2 from civet in comparison with human ACE2 are highlighted in red. (C) Amino acid changes in human and mouse ACE2. Amino acid changes in human ACE2 in comparison with mouse ACE2 are highlighted in red. P84 in human ACE2 does not interact with amino acids in S of SARS-CoV-2 but might affect the secondary structure. N90T and N322H destroy the N-glycosylation site in human ACE2.
FIG 3
FIG 3
(A) Amino acid changes between human ACE2 and dog ACE2. (B) Amino acid changes between human ACE2 and ferret ACE2. (C) Amino acid changes between human ACE2 and chicken ACE2.
FIG 4
FIG 4
The relative expression of ACE2 in pig (A) and dog (B) tissues was determined by qRT-PCR. (A) The relative expression of ACE2 in pig was determined in heart, liver, spleen, lung, kidney, duodenum, trachea, turbinate bone, and stomach. (B) The relative expression of ACE2 in dog was determined in heart, liver, spleen, lung, kidney, trachea, and turbinate bone. The experiments were repeated three times.
FIG 5
FIG 5
Amino acids in ACE2 important for binding to S of SARS-CoV-2. See the text for details.
FIG 6
FIG 6
(A) Amino acid changes in the RBD of S from SARS-CoV-2 and viruses from bats (white sticks) and pangolins (red stick). Hydrogen bonds between S from SARS-CoV-2 and the corresponding amino acids in ACE2, which are likely to be weakened or destroyed by the changes, are shown as dotted lines. (B) Amino acid changes between human ACE2 and pangolin ACE2.
FIG 7
FIG 7
Distribution of glycosylation sites and RGD motifs in S from SARS-CoV-2 and bat and pangolin CoV. (A) Schematic representation of SARS-CoV-2 S1 protein. The sequences of SARS-CoV-2 and bat and pangolin CoV were aligned using MegAlign. The RGD motif is highlighted in red. The RBM starting position is highlighted in blue. (B) Cryo-EM structure of S from SARS-CoV-2 (15). N-glycosylation sites unique for SARS-CoV-2 and bat and/or pangolin coronavirus are represented by red or orange spheres. The RGD amino acid sequences present in S of SARS-CoV-2 and Pangolin-CoV are represented by a cyan sphere. In a monomer in the open conformation, it is located near the ACE2 binding sites on top of the molecule. The location of the RGD motif in a monomer in a closed conformation (gray) is also indicated. The locations of the furin cleavage site present only in S of SARS-CoV-2 and of the S2´ cleavage site are also represented by red spheres.

Similar articles

Cited by

  • Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2.
    Hancock JT, Rouse RC, Stone E, Greenhough A. Hancock JT, et al. Animals (Basel). 2021 Mar 12;11(3):797. doi: 10.3390/ani11030797. Animals (Basel). 2021. PMID: 33809265 Free PMC article. Review.
  • Emergence and Characterization of a Novel Reassortant Canine Influenza Virus Isolated from Cats.
    Zhao J, He W, Lu M, He H, Lai A. Zhao J, et al. Pathogens. 2021 Oct 14;10(10):1320. doi: 10.3390/pathogens10101320. Pathogens. 2021. PMID: 34684269 Free PMC article.
  • Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage.
    Shukla N, Roelle SM, Snell JC, DelSignore O, Bruchez AM, Matreyek KA. Shukla N, et al. PLoS Pathog. 2024 May 20;20(5):e1012044. doi: 10.1371/journal.ppat.1012044. eCollection 2024 May. PLoS Pathog. 2024. PMID: 38768238 Free PMC article.
  • Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines.
    Guan X, Yang Y, Du L. Guan X, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):422-439. doi: 10.1080/14760584.2023.2211153. Expert Rev Vaccines. 2023. PMID: 37161869 Free PMC article. Review.
  • Animal models for COVID-19.
    Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Muñoz-Fontela C, et al. Nature. 2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23. Nature. 2020. PMID: 32967005 Free PMC article. Review.

References

    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Li M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JTK, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–1207. doi:10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069. doi:10.1001/jama.2020.1585. - DOI - PMC - PubMed
    1. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395:514–523. doi:10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed
    1. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YD, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, Pan HY, He WZ, Manuguerra JC, Fontanet A, Danchin A, Niccolai N, Li YX, Wu CI, Zhao GP. 2005. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A 102:2430–2435. doi:10.1073/pnas.0409608102. - DOI - PMC - PubMed
    1. Hu B, Zeng L-P, Yang X-L, Ge X-Y, Zhang W, Li B, Xie J-Z, Shen X-R, Zhang Y-Z, Wang N, Luo D-S, Zheng X-S, Wang M-N, Daszak P, Wang L-F, Cui J, Shi Z-L. 2017. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog 13:e1006698. doi:10.1371/journal.ppat.1006698. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources